News
Mar 12, 2026
Dr. Oksana Shynlova: Preventing Preterm Births and Supporting Pelvic Health
​
Dr. Shynlova is advancing women’s health across the lifespan by addressing two major challenges: preventing preterm birth and treating pelvic floor disorders. Her research explores uterine function during pregnancy and labour, the biological triggers of preterm births and age- and hormone-related tissue changes affecting pelvic health. By investigating hormone-based therapies and regenerative approaches, including patient-specific stem cells, her work aims to repair and strengthen pelvic tissues and enhance quality of life for women.
​
​

Aug 30, 2025
The 27th Medical Developmental Biology exchange course between Karolinska Institutet and University of Toronto
​
has come to an end. A fantastic week with great science, talented students and friends! Thanks to all the speakers and study visit instructors for taking the time and contributing to the course!
​
​
​

Summer Students at a Poster Session
July 24, 2025
Jun 24, 2025
LTRI researchers secure $2M grant to advance global study on cardiometabolic health in women and children
​
A team of researchers at the Lunenfeld-Tanenbaum Research Institute (LTRI), part of Sinai Health, have received a funding boost for a groundbreaking global study targeting the prevention of cardiometabolic disease in women and their children.
​
​
Now a team led by Dr. Ravi Retnakaran, a Clinician Scientist at LTRI, Drs. Stephen Lye and Rayjean Hung, both Senior Investigators at LTRI, has received a $ 2 million Team Grant from the Canadian Institutes of Health Research (CIHR) to investigate the diversity of responses in the HeLTI South Africa study.
Jun 10, 2025
Improving health at the earliest possible stage – before life begins
​
LTRI researchers are leading a groundbreaking international study to intervene in human health, starting at preconception.

HeLTI Research Committee members in 2023 with WHO Director General, Dr. Tedros Adhanom Ghebreyesus, the South African Minister of Health, Dr. Joe Phaahla and representatives from the South African Medical Research Council.




